SCHEMBL28043931

SCHEMBL28043931

Cc1cc(C)cc(-c2cc(NC3CCCCC3)nc(N)n2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 3/20 0.61
AURKA O14965 1/20 0.55
PDPK1 O15530 1/20 0.55
TGFBR1 P36897 1/20 0.55
ROCK1 Q13464 1/20 0.55
AURKB Q96GD4 1/20 0.55
HRH4 Q9H3N8 5/20 0.49
CDK1 P06493 2/20 0.47
CDK2 P24941 2/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ABL1 P00519 1/20 0.43
RIN1 Q13671 1/20 0.43
GPR39 O43194 1/20 0.41
KCNN2 Q9H2S1 1/20 0.40
KCNN3 Q9UGI6 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28043981 0.99 NUDT1 (0.58) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL28824469 0.96 NUDT1 (0.55) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL28043929 0.93 NUDT1 (0.51) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL28151074 0.83 SYK (0.44) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL15757620 0.82 AURKA (0.59) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL28152230 0.80 OPRK1 (0.41) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL14233966 0.79 NUDT1 (0.71) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL15757720 0.78 AURKA (0.61) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL15756972 0.77 AURKA (0.58) NUDT1AURKAPDPK1TGFBR1ROCK1
SCHEMBL12122741 0.76 AURKA (0.60) NUDT1AURKAPDPK1TGFBR1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 CN disclosed